Mtec prototype project resulting from the development of oral immunotherapy for the prevention of bacterial diarrheal disease solicitation (mtec-22-03-diarrheal). Project title is oral immunotherapy…
Active Awarded Last action
- Contract number
- W81XWH2290012
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $8,032,740
Award facts
- Contract value 100% obligated
- $8,032,740.08 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
- Primary consortia member
- Lumen Bioscience, Inc.
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $723,970 | |
| Supplemental Agreement for work within scope | $3,270,626 | |
| Other Administrative Action | $205,131 | |
| Original award | $3,833,014 |
About this award
This federal contract award was issued by the Defense Health Agency to the Medical Technology Enterprise Consortium (MTEC), a nonprofit organization that serves as a medical technology accelerator for the Department of Defense. The contract, valued at $8,032,740.08, is for the development of an oral immunotherapy for the prevention of bacterial diarrheal disease. The project, titled "Oral Immunotherapy for the Prevention of Bacterial Disease," is the result of a solicitation (MTEC-22-03-DIARRHEAL) and does not have a set-aside designation. MTEC holds a significant Other Transaction Indefinite Delivery Vehicle (IDV) agreement with the Defense Health Agency, valued at $3,466,511.50, which enables efficient task order awards for various medical technology development efforts, including projects related to traumatic brain injury solutions, regenerative medicine, infectious disease diagnostics, and medical training systems.
Description
Mtec prototype project resulting from the development of oral immunotherapy for the prevention of bacterial diarrheal disease solicitation (mtec-22-03-diarrheal). Project title is oral immunotherapy for the prevention of bacterial disease.
Quick answers
Who was awarded contract W81XWH2290012?
W81XWH2290012 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on July 22, 2022.
How much is contract W81XWH2290012 worth?
The government has obligated $8,032,740 on W81XWH2290012.
Is contract W81XWH2290012 an order under another contract?
Yes. W81XWH2290012 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract W81XWH2290012 competed?
The extent of competition for W81XWH2290012 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award